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Open Forum Infectious Diseases
MAJOR ARTICLE

Impact of Availability of Telehealth Programs on
Documented HIV Viral Suppression: A ClusterRandomized Program Evaluation in the Veterans Health
Administration
Michael E. Ohl,1,2,3 Kelly Richardson,1,2 Maria C. Rodriguez-Barradas,4 Roger Bedimo,5 Vincent Marconi,6,7,8 Jamie P. Morano,9,10 Michael P. Jones,11 and
Mary Vaughan-Sarrazin1,3
1

Background. Telehealth may improve care for people with HIV who live far from HIV specialty clinics. We conducted a clusterrandomized evaluation to determine the impact of availability of HIV telehealth programs on documented viral suppression in
Veterans Administration clinics.
Methods. In 2015–2016, people who previously traveled to HIV specialty clinics were offered telehealth visits in nearby primary care clinics. Patients were cluster-randomized to immediate telehealth availability (n = 925 patients in service areas of 13
primary care clinics offering telehealth) or availability 1 year later (n = 745 patients in 12 clinics). Measures during the evaluation
year included telehealth use among patients in areas where telehealth was available and documented HIV viral suppression (viral
load performed and <200 copies/mL). Impact of telehealth availability was determined using intention-to-treat (ITT) analyses that
compared outcomes for patients in areas where telehealth was available with outcomes for patients where telehealth was not available, regardless of telehealth use. Complier average causal effects (CACEs) compared outcomes for telehealth users with outcomes
for control patients with equal propensity to use telehealth, when available.
Results. Overall, 120 (13.0%) patients utilized telehealth when it was available. Availability of telehealth programs led to small
improvements in viral suppression in ITT analyses (78.3% vs 74.1%; relative risk [RR], 1.06; 95% confidence interval [CI], 1.01 to
1.11) and large improvements among telehealth users in CACE analyses (91.5% vs 80.0%; RR, 1.14; 95% CI, 1.01 to 1.30).
Conclusions. Availability of telehealth programs improved documented viral suppression. HIV clinics should offer telehealth
visits for patients facing travel burdens.
Keywords. HIV; randomized trial; telehealth; veterans.
In the United States, health care for people with HIV infection has historically been concentrated in HIV specialty clinics
in large urban areas [1, 2]. This specialized and centralized
delivery system promotes high-quality care for patients with
a complex and stigmatized condition, but also creates poor
geographic access to care for patients in outlying suburban
and rural areas far from specialty clinics [1, 3]. Telehealth
programs have potential to improve access to HIV specialty
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care in outlying areas, which could in turn improve retention
in care and treatment outcomes [4, 5]. The available evidence
indicates that telehealth programs deliver high-quality HIV
care, but prior studies have been small, suffered from selection
bias, or lacked a control group [6, 7].
The Veterans Affairs (VA) health care system is the largest
provider of HIV care in the United States and provides an opportunity to conduct large, randomized evaluations of HIV
telehealth programs [8]. Most veterans with HIV who live in
outlying suburban and rural areas travel to obtain care in HIV
specialty clinics in large urban facilities, with 21% traveling
more than 1 hour each way [6]. In response, some VA health
care systems have implemented HIV telehealth programs that
give patients the opportunity to receive HIV specialty care in
primary care clinics closer to their homes, instead of traveling
to the central HIV specialty clinic.
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METHODS

Systems redesign teams in the 3 networks implemented HIV
telehealth programs as local quality improvement initiatives.
A central evaluation team at the Veterans Rural Health Resource
Center – Iowa City (VRHRC-IC) measured program impacts
on patient outcomes using data routinely collected during
health care delivery and stored in VA administrative databases.
The evaluation was approved by the Institutional Review
Boards (IRBs) at the University of Iowa and Iowa City VA. Local
telehealth programs were classified as quality improvement activities by the VA Office of Rural Health and local IRBs.
Local Contexts and Telehealth Programs

Each care network included (1) a centrally located HIV clinic in
a large VA facility in an urban area with a population >1 million
and (2) 8–9 affiliated VA primary care clinics in surrounding
suburban and rural areas 14–114 miles from the HIV clinic.
HIV clinics provided comprehensive primary care for people
with HIV. Before telehealth programs, people with HIV who
lived closer to an outlying primary care clinic than to the HIV
clinic traveled to the HIV clinic for all care, with a minority
(10%–15%) having any visit history in the nearest primary care
clinic.
Teams working to establish HIV telehealth programs in each
network included a program coordinator within the HIV clinic
(registered nurse, nurse practitioner, or physician assistant), an
HIV specialist physician, and a facility telehealth coordinator.
Local teams participated in twice-monthly facilitation calls with
a team at the VRHRC-IC with experience implementing HIV
telehealth programs in the VA. Protocols for telehealth scheduling and visits followed local facility policies. Protocols varied
across networks but in all cases involved secure videoconferencing between HIV specialist providers in central HIV clinics
and patients in private rooms in primary care clinics. Telehealth
visits were conducted by the same providers conducting
in-person visits and included the same care elements. Telehealth
2 • ofid • Ohl et al

technicians in primary care clinics obtained vital signs and assisted with use of videoconferencing units and related technology as available to conduct limited physical exams (eg,
remote stethoscopes and high-resolution exam cameras for skin
and oral exams). Laboratory and in some cases basic radiology
facilities were available in primary care clinics.
Patient Cohort and Clinic Randomization

Because resource constraints made it unrealistic to implement
HIV telehealth visits in all primary care clinics simultaneously,
local teams agreed to random assignment of primary care clinics
to immediate initiation of HIV telehealth visits (ie, “intervention clinics”) or initiation 1 year later as controls. Assignment of
clinics and associated patients to intervention or control status
involved 3 steps. First, VRHRC-IC analysts used geographic information system (GIS) software (ArcGIS v10.4, Esri, Redlands,
CA) to divide geographic areas served by each of the 3 networks
into smaller service areas assigned to each primary care clinic.
Each service area consisted of the region that was closer to the
assigned primary care clinic than to any other network clinic
based on calculated existing road drive times (Figure 1, service
area map).
Second, analysts used administrative data to identify patients
in care in each HIV clinic in the year before telehealth program
initiation and assigned each patient to the nearest primary care
clinic based on residential address in the clinic’s service area. To
minimize travel burden, patients living closer to the HIV clinic
than to any primary care clinic (55%–75% across facilities) were
not offered telehealth and were thus excluded from the cohort.
Criteria for identifying patients in care were (1) any visits to
the HIV specialty clinic in the year before telehealth program
implementation and (2) International Classification of Diseases
9, Clinical Modification (ICD-9-CM), codes for HIV infection
(V08 and 042) at any time in the past.
Finally, primary care clinics (n = 25 total) within each network were pair-matched based on the number of HIV clinic
patients assigned to the clinic and the distance between the
primary care clinic and the HIV specialty clinic. One clinic in
each pair was randomly assigned to immediate initiation of
HIV telehealth programs (ie, intervention) or delayed initiation
1 year later (ie, control). Each clinic pair was assigned the same
index date for assessing outcomes after telehealth implementation, based on the date the intervention clinic implemented
telehealth.
Telehealth Initiation

Each local telehealth coordinator received a list of patients in
care in the HIV clinic in the past year with information on the
geographically assigned primary care clinic for each patient and
the estimated round-trip travel time each patient could save
using telehealth instead of traveling to the HIV clinic (ie, twice
the difference in drive time to the HIV clinic minus time to
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We conducted a cluster-randomized program evaluation in
3 VA health care systems that began HIV telehealth programs
in 2015–2016. We randomized groups of patients to the opportunity to use telehealth in primary care clinics closer to their
homes, not to actual telehealth use. Our goal was to determine
the effectiveness of HIV telehealth programs implemented
as quality improvement programs in real-world settings.
Specifically, we aimed to determine (1) the frequency of use of
HIV telehealth visits among patients offered telehealth instead
of traveling to the HIV clinic for care (ie, program uptake);
(2) the impact of the availability of telehealth programs on
documented HIV viral suppression among all patients offered
telehealth; and (3) the impact of telehealth on documented HIV
viral suppression among patients who used telehealth when it
was made available.

HIV Specialty Clinics
Control Clinics
Figure 1. Map showing geographic service areas of 9 primary care clinics in the Atlanta VA network based on existing road drive times. Service areas are irregularly shaped
due to variation in road networks. In the baseline year, patients traveled to the HIV specialty care clinic (see map legend) in the main facility for care. In the evaluation year,
patients were offered telehealth if they resided in the service area of clinics randomized to host HIV telehealth visits (shaded areas). Patients in these areas were given the
option of using telehealth visits in the nearest primary care clinic or continuing to travel to the HIV specialty clinic. Patients in service areas of control clinics (unshaded areas)
were offered telehealth at the end of the evaluation year. Patients living closer to the HIV specialty clinic than to a primary care clinic were not offered telehealth and not
included in analyses. See the “Methods” section for details.

primary care clinic hosting telehealth visits). Beginning approximately 3 months before HIV telehealth visits became available,
program coordinators reached out by telephone or in person
to patients living in the service area of telehealth clinics and
described the telehealth program, including the estimated travel
time the patient could save. Coordinators offered the patient a
choice of receiving HIV specialty care through telehealth visits
or continuing to travel to the HIV specialty clinic. In keeping
with the nature of the quality improvement programs, the only
criterion for offering telehealth to patients in the service area of
telehealth clinics was that the patient’s primary provider in the
HIV clinic confirm that telehealth visits were clinically appropriate based on the patient’s care needs. Over 90% of eligible
patients were offered telehealth according to logs maintained
by local coordinators. Patients choosing to use telehealth were
scheduled for appointments at previously assigned follow-up
intervals, as determined at their last HIV clinic visit. Patients

living in the service areas of control clinics were contacted
1 year later—at the end of the evaluation period—and offered
telehealth visits in control clinics.
Patient Characteristics and Outcomes

We used data routinely generated during care delivery and included in the VA’s Corporate Data Warehouse (eg, patient demographics, residential addresses, stop codes for clinic visits,
diagnosis codes, medication prescriptions, and laboratory
results) to follow patients assigned to intervention and control
clinics from the beginning of the year before telehealth program
initiation through the evaluation year. We excluded patients
who died during the evaluation year (Figure 2, flow diagram).
We created a series of variables for each patient indicating (1)
residence in the service area of a telehealth intervention or control clinic; (2) telehealth use, retention in care, and documented
viral suppression in the evaluation year (see below); and (3)
Telehealth and HIV Viral Suppression • ofid • 3
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Telehealth Clinics

Primary care clinics in 3 VA Networks (N = 25)
Network C clinics
randomized to
telehealth N = 4

Network A clinics
randomized to
telehealth N = 5

Network B clinics
randomized to
telehealth N = 4

Network A clinics
randomized to
control N = 4

Network B clinics
randomized to
control N = 4

Total clinics randomized
to telehealth N = 13

Total clinics randomized
to control N = 12

Patients living in service
area of telehealth clinics
at baseline N = 961

Patients living in service
area of control clinics
at baseline N = 769

Patients excluded due to death
in evaluation year N = 36

Network C clinics
randomized to
control N = 4

Patients excluded due to death
in evaluation year N = 24

Patients followed in administered data
and included in analyses N = 925
Patients with telehealth visit N = 120

Patients followed in administered data
and included in analyses
N = 745

risk-adjustment variables describing baseline patient characteristics before telehealth program initiation, including age,
sex, race (ie, white, black, other, or missing), time in HIV care
in the VA (ie, days from first HIV diagnosis code in the VA
to the beginning of the telehealth program), last CD4 count,
comorbidities, number of primary care clinic and HIV specialty
clinic visits in the prior year, estimated round-trip travel time
saved if the patient used telehealth in the nearest primary care
clinic instead of traveling to the HIV clinic, urban vs rural residence, and baseline measures for retention in care and viral
suppression in the prior year (see below). We used Rural Urban
Commuting Area (RUCA) codes linked to ZIP codes to classify
patient residences as urban or rural [9] and ICD-9-CM codes
and previously defined algorithms to create a series of indicator variables for presence of comorbidities in the prior year
(ie, hepatitis C infection, diabetes, hypertension, any cardiovascular disease, depression, malignancy, chronic kidney disease,
and alcohol or illicit substance use diagnoses) [10].
To assess telehealth program uptake, we used clinic stop
codes to create a binary variable indicating whether each patient used any HIV telehealth visits in the evaluation year and
count variables for the number of telehealth and in-person
HIV clinic visits. The primary outcome measure for each
patient was a binary variable indicating documented viral
suppression during the evaluation year based on viral load
measurements obtained during routine care delivery and included in administrative data, coded 1 if HIV viral load was
measured during the evaluation year and the last viral load
was <200 copies/mL, and otherwise 0. We included all patients
regardless of record of antiretroviral medication fills; 5.9% of
patients in control clinics and 5.3% of patients in telehealth
clinics had no antiretroviral fills. We examined documented
viral suppression (ie, viral load testing done and <200 copies/
mL) among all patients because we sought to examine a
comprehensive, pragmatic measure of viral load monitoring
4 • ofid • Ohl et al

and suppression in routine care delivery at a time when antiretroviral therapy was recommended for all patients with
monitoring of viral load at least every 6 months.
We measured retention in care during the evaluation year
using a dichotomous measure that required 2 HIV specialty
clinic visits—either in-person or telehealth—with a provider
(ie, MD, physician’s assistant, or advanced practiced nurse)
during the evaluation year. This is the visit-constancy measure
used to track retention in HIV care in the VA [11]. Reliable data
on missed clinic visits were not available.
Analyses

We compared baseline characteristics of patients assigned to intervention and control clinics using chi-square tests, adjusting
for clustering of patients within clinics. We determined the
number and proportion of patients assigned to intervention
clinics who had any telehealth visits in the evaluation year,
overall and by baseline characteristics, and the median number
of telehealth and in-person HIV clinic visits. We fitted a
multivariable logistic regression model for associations between
baseline patient characteristics and telehealth use.
We examined the impact of availability of telehealth
programs on retention in care and documented viral suppression at the population level using intention-to-treat (ITT)
analyses. These analyses compared outcomes among all patients
assigned to intervention clinics where telehealth was available
with outcomes of patients assigned to control clinics, regardless
of whether the patient used HIV telehealth visits. ITT analyses
employed generalized estimating equations (GEEs) with log
links and Poisson distributions to estimate relative risk of viral
suppression or retention in care while accounting for patient
clustering in primary care clinic service areas. Models included
an indicator variable for assignment to a telehealth clinic or
control clinic and patient characteristics that were significant
predictors of each outcome (eg, age, race, substance abuse
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Figure 2. Flowchart showing assignment of 25 primary care clinics and associated patients to telehealth and control status. Primary care clinics were affiliated with 3 HIV
specialty care clinics in 3 networks.

RESULTS

Analyses included 1670 patients in 25 clinics (925 in 13
telehealth intervention clinics and 745 in 12 control clinics).
Patients assigned to intervention and control clinics were similar for most characteristics (Table 1), with no differences in

baseline retention in care and viral suppression before randomization, comorbid conditions, rural residence, age, sex, or
prior use of VA health services. Most (71%) patients in areas of
telehealth clinics lived more than 60 minutes’ travel time from
the HIV clinic, and 27.4% could save more than 60 minutes’
travel time using telehealth.
Overall, 120 (13.0%) of 925 patients in service areas of intervention clinics used telehealth in the evaluation year (Table 2).
Telehealth use was strongly associated with the amount of travel
time a patient could save, ranging from 3.1% of patients saving
<15 minutes to 25.3% saving >60 minutes (P < .001). White
race, rural residence, baseline viral suppression, greater number
of primary care visits in the prior year, presence of a hypertension diagnosis, and absence of a substance use, depression, or
hepatitis C diagnosis were also associated with telehealth use
in bivariable analyses. Associations between patient characteristics and telehealth use were similar in multivariable analysis,
with exception of hepatitis C and substance use diagnoses and
rural residence (Supplementary Data).
Telehealth users had more total HIV clinic visits than control
group patients. Among users, the median number of telehealth
visits in the evaluation year (range) was 2 (1–6), and the median
number of total HIV clinic visits (ie, combined telehealth and
in-person) (range) was 4 (1–9). The median number of total
clinic visits in the control group (range) was 3 (0–14; P = .01 for
Kruskal-Wallis rank-sum test comparing total visits).
The availability of telehealth programs led to small
population-level improvements in documented viral suppression in ITT analyses that compared all patients residing in
service areas of telehealth clinics with all patients in areas of
control clinics (78.3% vs 74.1%; absolute difference, 4.3%; 95%
confidence interval [CI], 0.1% to 8.4%; RR, 1.06; 95% CI, 1.01
to 1.11; P = .01) (Table 3). There were large improvements in
documented viral suppression among telehealth users in CACE
analyses (91.5% vs 80.0%; absolute difference, 11.5%; 95% CI,
0.1% to 21.6%; RR, 1.14; 95% CI, 1.01 to 1.30; P = .03).
Patients residing in the service areas of telehealth clinics were
more likely to have viral load testing performed as part of routine care during the evaluation year compared with patients in
the area of control clinics (89.2% vs 83.4%) (Supplementary
Data). In sensitivity analyses including only patients with viral
load testing during the baseline and evaluation years (n = 1413),
neither the availability of telehealth programs (ie, ITT results)
nor actual telehealth use (ie, CACE results) was associated with
viral suppression (Supplementary Data). This indicates that
associations between telehealth programs and documented viral
suppression were related to increased performance of viral load
testing during routine care with telehealth, not with improved
viral suppression among those with testing completed.
Improvement in retention in care was greater in the CACE
analyses than in the ITT analyses, but neither reached statistical significance (ITT, 76.1% vs 72.6%; RR, 1.05; 95% CI, 1.00
Telehealth and HIV Viral Suppression • ofid • 5
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diagnosis, baseline measures of the outcome variable, time in
HIV care, and indicator variables for facility network).
To determine program impacts among telehealth users, we
also estimated the CACE of telehealth on viral suppression and
retention in care using principal stratification methods [12]. In
these analyses, the propensity of patients assigned to intervention clinics to use telehealth was estimated using logistic regression and observed baseline characteristics (ie, age, race, travel
time saved with telehealth visits, primary care clinic utilization
in the prior year, VA network, and comorbidities). Coefficients
associated with patient characteristics from the logistic regression model were applied to patients in control clinics to estimate the propensity of control patients to have used telehealth
had it been it available. Estimated propensities for telehealth
use were used to weight intervention and control patients to
create a pseudo-population of telehealth users assigned to intervention clinics and nonusers assigned to control clinics who
would have been equally likely to have used telehealth had it
been available to them. Subsequently, outcomes were compared
using weighted GEE models to control for patient clustering in
primary care catchment areas.
We used coefficients from the ITT and CACE analyses and
the method of recycled predictions to estimate risk-adjusted
viral suppression, retention in care, and the absolute difference
in each outcome between patients assigned to telehealth vs control clinics [13]. Confidence intervals around relative risk ratios,
and risk-adjusted outcome rates and absolute differences were
estimated by 1000 bootstrap resamples to estimate the standard
deviation of the coefficient associated with the telehealth indicator variable, risk-adjusted outcome rates, and absolute
differences. Bootstrapped samples were generated using a 2-part
sampling process that involved first sampling the assigned primary care clinics with replacement and then sampling patients
with replacement within the selected clinics to account for the
variability in the weights.
As telehealth programs could impact documented viral suppression by affecting both the performance of viral load testing
and viral suppression among those with viral load testing
performed, we also compared the proportions of patients
with viral load testing performed during the evaluation year
among those assigned to control vs telehealth clinics. We then
examined associations between the availability of telehealth
programs and viral suppression in analyses limited to patients
with viral loads performed during both the baseline year and
the evaluation year.

Table 1.

Patient Characteristics, by Residence in Service Area of a Control or Telehealth Intervention Clinic (n = 1670 Patients in 25 Clinics)

Patient Characteristics

Control
(n = 745)

Telehealth
(n = 925)

% (No.)

% (No.)

Age, y

P
.936

<30

5.1 (38)

3.0 (28)

30–39

9.3 (69)

10.6 (98)

Patient Characteristics

Control
(n = 745)

Telehealth
(n = 925)

% (No.)

% (No.)

Baseline CD4 count, cells/mm
Missing
<200

8.7 (65)

4.1 (38)

6.2 (46)

7.7 (71)
11.8 (109)

40–49

18.7 (139)

18.2 (168)

200–349

9.5 (71)

50–65

50.9 (379)

54.3 (502)

350–499

18.5 (138)

17.8 (165)

>65

16.1 (120)

14.0 (129)

≥500

57.1 (425)

58.6 (542)

Black

61.5 (458)

70.4 (651)

White

34.5 (257)

26.6 (246)

Other

1.6 (12)

1.7 (16)

Missing

2.4 (18)

1.3 (12)

95.8 (714)

96.2 (890)

Race

.366

Primary care clinic visits in prior year
.936

0

74.0 (551)

69.7 (645)

1

13.0 (97)

14.2 (131)

13.0 (97)

16.1 (149)

13.4 (100)

13.4 (124)

.376

13.7 (102)

11.9 (110)

.930

48.1 (358)

44.4 (411)

≥2
.531

Years in HIV care

Inpatient admission in prior year

.986

HIV clinic visits in prior year

<1

7.4 (55)

4.3 (40)

1–5

26.6 (198)

26.5 (245)

>5

66.0 (492)

69.2 (640)

.240

1
2–3

Travel time to HIV clinic,
roundtrip min

4–9

35.2 (262)

39.8 (368)

≥10

3.1 (23)

3.9 (36)

Travel time saved with telehealth, min

<60

10.7 (80)

29.0 (268)

60–89

39.6 (295)

36.2 (335)

.207

<15

14.5 (108)

13.8 (128)

15–29

17.5 (130)

17.7 (164)

90–119

18.4 (137)

13.3 (123)

30–59

27.1 (202)

41.1 (380)

≥120

31.3 (233)

21.5 (199)

≥60

40.9 (305)

27.4 (253)

.706

Baseline retention in care

79.7 (594)

81.5 (754)

.417

Substance use diagnosis

20.0 (149)

24.8 (229)

.870

Baseline viral suppression

82.3 (613)

80.9 (748)

.231

Diabetes

13.6 (101)

15.1 (140)

.744

Depression

36.8 (274)

35.9 (332)

.622

Hepatitis C

10.7 (80)

11.8 (109)

.900

Hypertension

42.2 (314)

43.2 (400)

.978

Liver disease

15.4 (115)

13.4 (124)

.405

Antiretroviral receipt

94.5 (704)

95.8 (886)

.178

Residence
.658

Chronic kidney disease

1.5 (11)

1.4 (13)

.832

Urban

82.2 (612)

82.9 (767)

Malignancy

8.1 (60)

6.8 (63)

.100

Rural

17.7 (132)

16.5 (153)

Cardiovascular disease

3.9 (29)

2.1 (19)

.204

Missing

0.1 (1)

0.5 (5)

to 1.10; P = .06; CACE, 86.4% vs 76.5%; RR, 1.13; 95% CI, 0.98
to 1.32; P = .10).
DISCUSSION

We conducted a pragmatic experiment in health care delivery that randomized groups of patients to the opportunity
to receive HIV specialty care via telehealth in nearby primary care clinics, instead of traveling to a distant HIV clinic.
We randomized groups of patients to telehealth availability;
patients in areas where telehealth was made available could
then choose to have telehealth visits in a nearby primary care
clinic or continue to travel to the HIV specialty clinic. Our
findings describe the impact of HIV telehealth programs
implemented as quality improvement programs in real-world
settings and are most relevant to other urban HIV clinics that
serve patients who travel long distances to the clinic from outlying suburban and rural areas [1].
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Thirteen percent of patients living in areas where telehealth
was available completed a telehealth visit in the evaluation year.
Low telehealth use likely reflected the fact that patients in these
3 health care systems were already accustomed to traveling to
the HIV clinic for care, and many could save relatively little
travel time by using telehealth. Not surprisingly, the proportion of patients using telehealth increased as travel time saved
increased, with 25.3% using telehealth if they could save more
than an hour. Other factors that may have impacted telehealth
use include perceived HIV stigma in primary care clinics, visit
convenience, transportation options, and comfort with specific
aspects of telehealth visits. An ongoing study is exploring how
these factors influence telehealth use.
The availability of telehealth programs was associated with
small improvements in documented viral suppression in ITT
analyses that compared all patients in areas where telehealth
was available with patients in areas of control clinics where
telehealth was not available, regardless of telehealth use. ITT
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Sex male

P

3

Cardiovascular disease

Malignancy

Chronic kidney disease

Liver disease

Hepatitis C

Hypertension

Depression

Diabetes

Substance use diagnosis

Residence

Sex

Age, y

Race

10.5 (2)
13.0 (118)

No

12.7 (109)

No

Yes

17.5 (11)

Yes

7.7 (1)
13.1 (119)

No

No

Yes

8.9 (11)
13.6 (109)

Yes

10.1 (11)
13.4 (109)

No

9.7 (51)

No

Yes

17.3 (69)

14.2 (84)

No

Yes

10.8 (36)

Yes

15.7 (22)
12.5 (98)

No

14.4 (100)

No

Yes

8.7 (20)

Yes

26.1 (40)
40.0 (2)

Rural

10.2 (78)

Missing

Urban

17.1 (6)

Female

21.7 (28)

>65
12.8 (114)

12.8 (64)

50–65

Male

4.1 (4)
13.1 (22)

30–39

40–49

7.1 (2)

<30

.548

.513

.618

.056

.016

<.001

.033

.172

.029

.030

.613

.077

>5

8.3 (1)

≥60

30–59

15–29

<15

Travel time saved with telehealth, min

≥240

180–239

120–179

<120

Travel time to HIV clinic, min

No

Yes

Inpatient admissions

≥10

4–9

2–3

1

HIV clinic visits

≥2

1

0

Primary care clinic visits

≥500

350–499

200–349

<200

Missing

Baseline CD4, cells/mm3

No

Yes

Antiretroviral receipt in prior year

No

Yes

Baseline viral suppression

No

Yes

Baseline retention in care

12.5 (2)

Other

Missing

<1
1–5

25.6 (63)

Time in HIV care, y

Patient Characteristics (cont.)

White

.004

P

8.3 (54)

Telehealth Use, % (No.)

Black

Patient Characteristics

Table 2.   Telehealth Use in Evaluation Year Among 925 Patients in Areas of Telehealth Intervention Clinics
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25.3 (64)

11.8 (45)

4.3 (7)

3.1 (4)

21.1 (42)

20.3 (25)

12.5 (42)

4.1 (11)

13.1 (105)

12.1 (15)

11.1 (4)

12.8 (47)

13.9 (57)

10.9 (12)

29.5 (44)

13.7 (18)

9.0 (58)

13.7 (74)

13.9 (23)

9.2 (10)

14.1 (10)

7.9 (3)

10.3 (4)

13.1 (116)

4.5 (8)

15.0 (112)

11.1 (19)

13.4 (101)

13.3 (85)

12.7 (31)

10.0 (4)

Telehealth Use, % (No.)

<.001

.018

.800

.355

.014

<.001

.256

<.001

.391

.105

P

Table 3.

Impact of Telehealth Program Availability on Retention in HIV Care and Documented Viral Suppressiona
Telehealth Intervention Clinics

Control Clinics

Absolute Difference (95% CI)

Relative Risk (95% CI), P

ITT
Retention in care

76.1 (75.4 to 77.0)

72.6 (71.8 to 73.4)

3.6 (0.0 to 7.7)

1.05 (1.00 to 1.10), .06

Documented viral suppression

78.3 (77.2 to 79.5)

74.1 (73.0 to 75.2)

4.3 (0.1 to 8.4)

1.06 (1.01 to 1.11), .01

CACE
Retention in care

86.4 (76.2 to 95.3)

76.5 (68.5 to 84.7)

9.9 (–1.8 to 22.2)

1.13 (0.98 to 1.32), .10

Documented viral suppression

91.5 (84.0 to 97.4)

80.0 (72.3 to 88.1)

11.5 (0.1 to 21.66)

1.14 (1.01 to 1.30), .03

Abbreviations: CACE, complier average causal effect; CI, confidence interval; ITT, intention to treat.
a
Results are the adjusted proportion of patients experiencing outcomes in telehealth and control clinics, absolute difference in outcomes, and relative risk for outcomes, with 95% confidence intervals in parentheses. ITT analyses compared patients in service areas of telehealth intervention clinics with patients in areas of control clinics, regardless of telehealth use, and
were adjusted for patient age, race, baseline measure of outcome variable, time in HIV care, and facility. CACE analyses compared telehealth users with patients in areas of control clinics
with equal propensity to use telehealth, if available.
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CONCLUSIONS

Use of telehealth programs was low overall but increased
with increasing travel time saved. The availability of
telehealth programs was associated with small populationlevel improvements in documented viral suppression among
all patients in service areas of telehealth clinics and large
improvements among program users. HIV clinics should offer
telehealth visits for patients facing travel burdens.
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